Stephen David Prior, Chief Strategy Officer: AN2 Therapeutics ANTX Sell · Filed 25/01/07

Trade details

Type: Insider sale
Amount: $2,718.86
Shares · price: 2,029 sh · $1.34 a share
Held after: 33,313 sh
Stock: AN2 Therapeutics ANTX
Person: Stephen David PriorChief Strategy Officer
Trade date: 25/01/03
Filed: 25/01/07
Days to filing: 4 days

Sold 5.7% of holdings

Share of holding sold: 5.7%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/04~25/02/02

Stephen David Prior's recent trades

Stephen David PriorChief Strategy Officer
SellAN2 Therapeutics
Sell
AN2 Therapeutics
ANTX
$3,604
3,604 sh
$3,604
Filed 01/07
Traded 01/05
Stephen David PriorChief Strategy Officer
SellAN2 Therapeutics
Sell
AN2 Therapeutics
ANTX
$2,887
2,858 sh
$2,887
Filed 01/07
Traded 01/06
Stephen David PriorChief Strategy Officer
SellAN2 Therapeutics
Sell
AN2 Therapeutics
ANTX
$872
765 sh
$872
Filed 25/11/06
Traded 25/11/04